Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 4 von 153
Trends in pharmacological sciences (Regular ed.), 2006, Vol.27 (1), p.41-47
2006
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Chemokine blockers – therapeutics in the making?
Ist Teil von
  • Trends in pharmacological sciences (Regular ed.), 2006, Vol.27 (1), p.41-47
Ort / Verlag
England: Elsevier Ltd
Erscheinungsjahr
2006
Quelle
MEDLINE
Beschreibungen/Notizen
  • Chemokines are a family of small chemoattractant cytokines that have an important role in controlling leukocyte migration. The finding that some chemokines and their receptors are upregulated in both acute and chronic inflammatory diseases, and that they are key players in the development of AIDS, has provided the pharmaceutical industry with new targets for therapeutic intervention in these diseases. Although the chemokine system shows apparent redundancy in vitro, target validation is possible largely through expression studies in human disease tissues and the use of transgenic and knockout mice as disease models. Several approaches are being developed to block the effects of chemokines, including small-molecule antagonists of chemokine receptors, modified chemokines and antibodies directed against chemokine receptors. Here, we describe the rationale behind these different approaches, the pitfalls that have been encountered and future perspectives.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX